Investors Title (NASDAQ:ITIC) Sees Unusually-High Trading Volume - What's Next?

Key Points

• Investors Title shares saw unusually high trading activity, with roughly 101,362 shares changing hands—168% above the prior session—and the stock rising 0.8% to about $289.
• Analyst sentiment remains broadly positive: Weiss Ratings upgraded the stock, while Wall Street Zen downgraded it to “hold”; MarketBeat reports a consensus “Buy” rating.
• The company reported quarterly earnings of $7.73 per share on $81.71 million in revenue and paid a $0.46 quarterly dividend, equal to a 0.6% yield. Institutional ownership stands at 41.4%, with several major investors recently building positions.

Shares of Investors Title Company (NASDAQ:ITIC - Get Free Report) saw unusually-strong trading volume on Wednesday. Approximately 101,362 shares changed hands during mid-day trading, an increase of 168% from the previous session's volume of 37,759 shares. The stock last traded at $289.0130 and had previously closed at $286.64.

Analyst Ratings Changes

Several brokerages have recently issued reports on ITIC. Weiss Ratings upgraded shares of Investors Title from a "buy (b)" rating to a "buy (b+)" rating in a report on Tuesday. Wall Street Zen lowered shares of Investors Title from a "buy" rating to a "hold" rating in a report on Wednesday, August 5th. One research analyst has rated the stock with a Buy rating. According to data from MarketBeat.com, Investors Title has a consensus rating of "Buy".

Investors Title Trading Up 0.8%

The business has a fifty day moving average of $292.86 and a 200-day moving average of $269.10. The company has a market cap of $546.33 million, a PE ratio of 13.53 and a beta of 0.60.

Investors Title (NASDAQ:ITIC - Get Free Report) last released its quarterly earnings data on Thursday, August 6th. The insurance provider reported $7.73 earnings per share for the quarter. Investors Title had a return on equity of 14.62% and a net margin of 13.80%. The business had revenue of $81.71 million during the quarter.

Investors Title Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 15th. Shareholders of record on Tuesday, September 1st were paid a dividend of $0.46 per share. This represents a $1.84 annualized dividend and a yield of 0.6%. The ex-dividend date was Tuesday, September 1st. Investors Title's dividend payout ratio (DPR) is currently 8.62%.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the company. BlackRock Inc. purchased a new position in Investors Title during the second quarter valued at $32,062,000. Aristides Capital LLC increased its stake in Investors Title by 13.6% during the first quarter. Aristides Capital LLC now owns 18,953 shares of the insurance provider's stock worth $4,119,000 after acquiring an additional 2,273 shares during the last quarter. Bank of New York Mellon Corp purchased a new position in shares of Investors Title in the 2nd quarter worth approximately $3,588,000. Bank of America Corp DE bought a new position in Investors Title during the second quarter valued at $1,554,000. Finally, GSA Capital Partners LLP purchased a new stake in Investors Title in the 2nd quarter worth about $777,000. 41.40% of the stock is owned by hedge funds and other institutional investors.

Investors Title Company Profile

Investors Title Company NASDAQ: ITIC is an insurance holding company that provides title insurance and related real estate services. Through its title insurance subsidiaries, the company protects property owners and mortgage lenders against certain losses arising from defects, liens, or other issues affecting title to real estate.

The company's offerings include owners' and lenders' title insurance, title searches and examinations, escrow and closing services, and other title-related services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.